MedTrace Logo

If Chronic Gallbladder Diseases Increase the Incidence of PEC

NCT04242394 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1019

Last updated 2025-12-19

No results posted yet for this study

Summary

This is a prospective, multi-centre trial conducts at 4 ERCP centers in China designed to determine if chronic gallbladder diseases increase the incidence of Post-Endoscopic Retrograde Choledochopancreatography-Choledocholithiasis (PEC)

Conditions

  • Cholecystitis

Interventions

PROCEDURE

ERCP

Routine ERCP procedures with gallbladder in situ patient

Sponsors & Collaborators

  • Hepatopancreatobiliary Surgery Institute of Gansu Province

    lead OTHER

Principal Investigators

  • Wenbo Meng, M.D., Ph. D. · Hepatopancreatobiliary Surgery Institute of Gansu Province

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-14
Primary Completion
2024-11-16
Completion
2024-11-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04242394 on ClinicalTrials.gov